Core Insights - The Chinese nuclear technology application industry has made significant progress, with the industry scale reaching new heights and achieving breakthroughs in high-quality development [1] Industry Overview - The output value of China's nuclear technology application is projected to reach 890 billion yuan in 2024, accounting for 0.66% of GDP, which is a 27% increase from 2022 [1] - The compound annual growth rate from 2020 to 2024 is estimated at 15.6% [1] - The distribution of application sectors includes industrial applications (42.7%), nuclear medicine (21.7%), agricultural applications (13.9%), and foundational industries (10.3%) [1] Workforce and Infrastructure - By the end of 2024, there will be approximately 140,000 legal entities engaged in radioactive isotope/radiation device operations, employing around 960,000 people, representing growth of 34% and 17% respectively since 2022 [1] - The number of radiation devices in use is about 320,000 units, with 172,000 radioactive sources, marking increases of 17% and 4.9% respectively since 2022 [1] - There are 42 national large-scale scientific facilities related to nuclear technology, with 18 operational research reactors, including 5 capable of isotope production [1] Technological Advancements - The industry has seen rapid development in irradiation processing and nuclear medical applications, with growth rates exceeding double digits [2] - The production value of nuclear agricultural applications has surpassed 100 billion yuan, and the market penetration of various nuclear analysis and instrumentation products continues to rise [2] - Significant advancements include the approval of the world's first phased array CT and the domestic first photon counting spectral CT, among other innovations [3] International Collaboration - China has opened 12 top nuclear research facilities to the international community and established 8 IAEA collaboration centers [3] - Equipment for Thailand's micro-reactor project has been shipped, and there is a growing trend in the export of high-end nuclear medical devices and industrial irradiation equipment [3]